Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45,547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial.
Cruz-Lim EM, Mou B, Baker S, Arbour G, Stefanyk K, Jiang W, Liu M, Bergman A, Schellenberg D, Alexander A, Berrang T, Bang A, Chng N, Matthews Q, Carolan H, Hsu F, Miller S, Atrchian S, Chan E, Ho C, Mohamed I, Lin A, Huang V, Mestrovic A, Hyde D, Lund C, Pai H, Valev B, Lefresne S, Tyldesley S, Olson R. Cruz-Lim EM, et al. Among authors: liu m. Clin Oncol (R Coll Radiol). 2024 Mar;36(3):148-156. doi: 10.1016/j.clon.2023.11.041. Epub 2023 Dec 3. Clin Oncol (R Coll Radiol). 2024. PMID: 38087705 Clinical Trial.
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II Trial.
Cruz-Lim EM, Mou B, Jiang W, Liu M, Bergman A, Schellenberg D, Alexander A, Berrang T, Bang A, Chng N, Matthews Q, Carolan H, Hsu F, Miller S, Atrchian S, Chan E, Ho C, Mohamed I, Lin A, Huang V, Mestrovic A, Hyde D, Lund C, Pai H, Valev B, Lefresne S, Tyldesley S, Olson R, Baker S. Cruz-Lim EM, et al. Among authors: liu m. Clin Oncol (R Coll Radiol). 2024 Mar;36(3):141-147. doi: 10.1016/j.clon.2024.01.007. Epub 2024 Jan 17. Clin Oncol (R Coll Radiol). 2024. PMID: 38296662 Clinical Trial.
Unlocking the dual role of LSD1 in tumor immunity: innate and adaptive pathways.
Zhang Y, Guo N, Zhu H, Liu M, Hao J, Wang S, Guo T, Mamun M, Pang J, Liu Q, Zheng Y, Liu H, Si P, Zhao L. Zhang Y, et al. Among authors: liu m. Theranostics. 2024 Oct 21;14(18):7054-7071. doi: 10.7150/thno.102037. eCollection 2024. Theranostics. 2024. PMID: 39629133 Free PMC article. Review.
45,547 results
You have reached the last available page of results. Please see the User Guide for more information.